Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

As an integral part of the immune system, the lymphatics enable immune surveillance by shepherding the migration of antigen-laden immune cells to draining lymph nodes (dLNs), as well as handling the clearance of macrophages and neutrophils from sites of injury and infection. In addition, the lymphatics play key roles as conduits for tumour metastasis. The molecular mechanisms controlling entry to the lymphatics in these different contexts have yet to be fully elucidated. However, it is clear that in most cases they involve coordination between the processes of chemotaxis and cell adhesion within the specialized endothelial junctions of initial lymphatic capillaries for transit to the vessel lumen. A fundamental mediator of such adhesion is the large matrix glycosaminoglycan hyaluronan, and growing evidence indicates anchorage of hyaluronan to the surface of migrating cells and appropriate engagement with LYVE-1, its’ primary receptor in lymphatic endothelium are critical to the entry process. The present chapter outlines the main properties of hyaluronan and how they support the trafficking of leucocytes for immunity and inflammation. In addition, it discusses the evidence that hyaluronan may also aid the invasion and systemic dissemination of metastasizing tumour cells.

Original publication

DOI

10.1007/978-3-030-93084-4_22

Type

Book title

Cancer Metastasis Through the Lymphovascular System

Publication Date

01/01/2022

Pages

231 - 240